DV
Dividend Vision

XBIX — Corgi U.S. Biotech 2x Daily ETF

Corgi U.S. Biotech 2x Daily ETF (XBIX)

XBIX carries a 0.45% expense ratio. Total return is 41.7% over the past 0.2 years, 38.5 points ahead of SPY at 3.2%.

XBIX is a leveraged equity ETF that provides 2x daily exposure to the U.S. biotech sector, designed for short-term tactical positioning rather than buy-and-hold investing. The fund carries a 0.45% expense ratio and does not pay distributions, making it unsuitable for income-focused investors. This product appeals primarily to experienced traders seeking amplified exposure to biotech price movements, though leverage magnifies both gains and losses on a daily basis.

XBIX key facts

Issuer
Corgi Strategies
Asset type
ETF
Asset class
Equity
Inception date
06/03/2026
Expense ratio
0.45%
Last close
$36.59
AUM
$642,508
Average volume
100.0